This firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, has a ceiling value of $4,311.35. The contract was awarded by the Defense Logistics Agency (DLA) and covers the delivery of 4,566,371,684 units of the prescription drug Xtandi 40 mg capsule, with an ultimate completion date of November 8, 2024. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities worldwide.
Generated 2/6/25, 9:27 AM